Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.
暂无分享,去创建一个
Pascal Leprince | Christoph Nix | Cristian Preda | Marjorie Richardson | Antoine Capel | Mouhamed Moussa | Alain Carpentier | Thomas Hubert | Piet Jansen | Christian Latremouille | P. Leprince | A. Carpentier | C. Preda | G. Lemesle | P. Lenting | C. Denis | S. Susen | J. Amour | C. Delhaye | F. Vincent | H. Spillemaeker | A. Rauch | B. Staels | N. Rousse | A. Vincentelli | Y. Sottejeau | E. Robin | E. Van Belle | D. Smadja | Bart Staels | C. Latrémouille | Eric Van Belle | Peter J Lenting | A. Dupont | Mickael Rosa | C. Nix | A. Capel | P. Jansen | G. Schurtz | D. Corseaux | N. Debry | E. Jeanpierre | C. Paris | V. Loobuyck | C. Caron | André Vincentelli | Delphine Corseaux | Sophie Susen | T. Hubert | A. Coisne | Augustin Coisne | Emmanuel Robin | Annabelle Dupont | David M Smadja | Antoine Rauch | Flavien Vincent | Valentin Loobuyck | Julien Amour | Gilles Lemesle | Hugues Spillemaeker | Nicolas Debry | Natacha Rousse | Guillaume Schurtz | Cédric Delhaye | Camille Paris | Emmanuelle Jeanpierre | Mickaël Rosa | Yoann Sottejeau | Svenja Barth | Claudia Mourran | Valérie Gomane | Claudine Caron | Alexandre Ung | Cécile Denis | M. Richardson | M. Moussa | A. Ung | Svenja Barth | Claudia Mourran | Valérie Gomane
[1] F. Kallel,et al. Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[2] G. Ewald,et al. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure , 2017, Circulation.
[3] Antoine Capel,et al. The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves. , 2017, Journal of cardiothoracic and vascular anesthesia.
[4] F. Mouquet,et al. Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions. , 2015, Circulation research.
[5] Snehal R. Patel,et al. Creating adequate pulsatility with a continuous flow left ventricular assist device: just do it! , 2016, Current opinion in cardiology.
[6] Myron N. Chang,et al. The Incidence, Predictors and Outcomes of Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device (LVAD) , 2015, Digestive Diseases and Sciences.
[7] E. Belle,et al. Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis , 2015, Journal of thrombosis and haemostasis : JTH.
[8] G. Lemesle,et al. Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement. , 2016, The New England journal of medicine.
[9] Gregory J. Stoddard,et al. Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II , 2013, Circulation. Heart failure.
[10] D. Tassaux,et al. Veno-venous extracorporeal membrane oxygenation: cannulation techniques. , 2016, Journal of thoracic disease.
[11] Gregory A. Ewald,et al. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.
[12] K. Muthiah,et al. Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] G. Remuzzi,et al. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. , 1997, Blood.
[14] C. Bara,et al. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. , 2014, JACC. Heart failure.
[15] Wei Li,et al. Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways , 2013, Cell Research.
[16] S. Susen,et al. Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.
[17] N. Uriel,et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. , 2010, Journal of the American College of Cardiology.
[18] Andrew Boyle,et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. , 2009, The Journal of thoracic and cardiovascular surgery.
[19] Young Choi,et al. Rotary pump speed modulation for generating pulsatile flow and phasic left ventricular volume unloading in a bovine model of chronic ischemic heart failure. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[20] M. Mehra,et al. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[21] Steven C. Koenig,et al. Defining pulsatility during continuous-flow ventricular assist device support. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[22] Yoshifumi Naka,et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.